Phase 4 Allograft Clinical Trials
3 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–3 of 3 trials
Recruiting
Phase 4
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Graft RejectionGraft FailureRenal Failure Chronic+2 more
Hospital Universitari Vall d'Hebron Research Institute202 enrolled1 locationNCT06676696
Terminated
Phase 4
A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone for the treatment of chronic active antibody mediated rejection
chronic active antibody mediated rejection of the renal allograft
Dr William Mulley50 enrolled7 locationsACTRN12612000252819
Completed
Phase 4
Influence on hemodynamics of conversion from Calcineurin Inhibitor to Sirolimus in Renal and Liver Transplant patients
renal allograft recipients or liver allograft recipients
University Hospital Bern40 enrolled1 locationACTRN12610000835044